The Fanconi anemia pathway and ubiquitin
Fanconi anemia (FA) is a rare genetic disorder characterized by aplastic anemia, cancer/leukemia susceptibility and cellular hypersensitivity to DNA crosslinking agents, such as cisplatin. To date, 12 FA gene products have been identified, which cooperate in a common DNA damage-activated signaling p...
Main Authors: | Jacquemont, Céline, Taniguchi, Toshiyasu |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2007
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2106361/ |
Similar Items
-
Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin
by: Jacquemont, Céline, et al.
Published: (2012) -
Mutated Fanconi anemia pathway in non-Fanconi anemia cancers
by: Shen, Yihang, et al.
Published: (2015) -
The Fanconi Anemia Pathway of Genomic Maintenance
by: Levitus, Marieke, et al.
Published: (2006) -
BLM promotes the activation of Fanconi Anemia signaling pathway
by: Panneerselvam, Jayabal, et al.
Published: (2016) -
The 13th Fanconi Anemia Gene Identified: FANCI – Importance of the ‘Fanconi Anemia Pathway’ for Cellular Oncology
by: Meijer, Gerrit A.
Published: (2007)